Clinical Trials Browser

Phase 2 × Interventional × ontuxizumab × Clear all

NCT01507545 2022-05-06

Morphotek Investigation in Colorectal Cancer: Research of MORAb-004 (MICRO)

Phase 2 Terminated

154 enrolled 13 charts

Gastrointestinal

Colorectal Neoplasms

NCT01335009 2021-09-01

Efficacy Study of Pharmacokinetic(PK)/Pharmacodynamic(PD) Relationship of Monotherapy MORAb-004 in Metastatic Melanoma

Phase 2 Completed

76 enrolled 13 charts

Melanoma, Neoplasm Metastasis

NCT01574716 2019-08-21

SOURCE

Phase 2 Completed

209 enrolled 18 charts

Sarcoma